In the News May 27, 2016

Law360 | Don’t Miss It: Hot Deals & Firms We’re Following This Week

Mark Ray and Sarah Ernst are noted for advising Arbor Pharmaceuticals in its acquisition of XenoPort for a total equity value of approximately $467 million.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.